Article
BRAF mutation in myeloid neoplasm: incidences and clinical outcomes.
Leukemia & lymphoma - 1 Sept 2024
Abuasab Tareq, Mohamed Shehab, Pemmaraju Naveen, Kadia Tapan M, Daver Naval, DiNardo Courtney D, Ravandi Farhad, Qiao Wei, Montalban-Bravo Guillermo, Borthakur Gautam
Abstract excerpt
The presence of BRAF mutation in hematological malignancies, excluding Hairy cell leukemia, and its significance as a driver mutation in myeloid neoplasms (MNs) remains largely understudied. This research aims to evaluate patient characteristics and outcomes of BRAF-mutated MNs. Among a cohort of 6667 patients, 48 (0.7%) had BRAF-mutated MNs. Notably, three patients exhibited sole BRAF mutation, providing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
